Weight-loss drugs reviewed

New obesity medications, including Belviq, pictured here, have cleared an FDA gantlet. A new report suggests a few changes for future deliberations.
Food and Drug Administration
Copyright © 2017, Los Angeles Times
EDITION: California | U.S. & World
69°